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GLOSSARY
12 x shot gun status-is also known as genome shotgun sequencing. Long genomes
cannot be sequenced in one piece; so the DNA is spliced into random fragments and
the fragments are sequenced. This is done at 12x or greater coverage to ensure
accuracy.
-hemolysis- complete lysis of red blood cells in media; it is a clearing of the medium
around the growth.
Ante-penultimate- third from last.
Cell pellet- is the solid material at the bottom of a tube after centrifugation of the
bacterial culture.
Culture filtrate- cultured filtrate is the supernatant of a bacterial culture has been
centrifuged. It is no longer media because it has been exposed to a bacterial culture
for a period of time and can contain toxins, proteins, etc. that was not originally in the
media.
Cytokines- are a group of proteins and peptides used for cell-to-cell signaling. They are
often used in innate and adaptive immune responses. Two much cytokine production
is known as a cytokine storm causing accumulation of too many immune cells and
potential blockage of airways or blood.
Heat Stable toxin(s)- is/are the heat stable toxin(s) purified by autoclaving the cultured
filtrate.
LD50- a dose required to kill half of a tested population using a toxic substance or
radiation.
Malonyl CoA- is a derivative of the coenzyme A and is important in fatty acid
elongation.
Mesophilic- organisms that grow optimally at temperatures between 20°C and 45°C.
Monkey Emesis Assay- The feeding of emetic and non-emetic toxins to monkeys to the
observe the effect(s) of different doses.
vii
GLOSSARY
Oropharynx- oral part of the pharynx, from the soft palate of the mouth to the hyphoid
bone.
Penultimate- next to last.
Psychrophilic- organisms that grow optimally at low temperatures, 15°C and below.
Rectal Tenesmus- a feeling of incomplete defecation, the inability or difficulty to empty
bowel at defecation.
Sepsis- has two main definitions: (1) pathogenic organisms or toxins in the blood or
tissues (2) a condition relating to poisoning from pathogenic organisms or toxins in
the blood or tissues.
Vacuolation- the formation or multiplication of vacuoles, which are typically membrane
bound components of the cytoplasm.
Variable Number Tandem Repeat- is a genetic tool using variable numbered (14 to 100
nucleotides) sequenced nucleotides that are in clusters that repeat in tandem from 4-
40 times.
viii
ABBREVIATIONS
ANOVA- analysis of variance
ATCC- American Type Culture Collection.
BHI- Brain Heart Infusion
CDC- Center for Disease Control
CF- Culture Filtrate
DMSO-Dimethyl Sulfoxide
DMEM- Dulbecco’s Modified Eagles Minimal Essential Medium
FBDO- Food Born Disease Outbreak
GCMS- Gas Chromatography/ Mass Spectra
HuH-7- Hepatocellular Carcinoma Cell Line
LRN- Laboratory Response Network
MTT-3-[4,5-dimethylithiazol-2-yl]-2,5-dipheyl tetrazolium bromide
NIH- National Institutes of Health
OD- Optical Density
TSA II- Trypticase Soy Agar with 5% Sheep Blood
1CHAPTER I
INTRODUCTION
The intentional attempt to spread anthrax through the U.S. Postal Service in 2001
(Inglesby et al., 2001) revealed a disturbing picture of a poorly structured and ill-
equipped system to deal with consequences of such a bioterrorism event. The realization
that neither the U.S. nor the rest of the world is prepared for the repercussions of
bioterrorism has sparked research directed toward obtaining a better understanding of
biological warfare agents.
Anthrax is caused by Bacillus anthracis. In 1877, Robert Koch used B. anthracis
in his classic studies of microbial etiology. The studies later led to the investigation of
tuberculosis and the formulate Koch Postulates regarding the germ theory of disease
(Prescott, Harley, & Klein, 2002). B. anthracis is a Gram-positive, rod-shaped, spore-
forming bacterium that measures approximately three to five micrometers (µm) in length
(Todar, 2005). B. anthracis is a facultative anaerobe that produces ellipsoidal endospores
which resist staining and are centrally located (Todar, 2005). B. anthracis is
differentiated from similar species using growth on differential media, molecular
genetics, and traditional biochemical analyses.
2B. anthracis is found globally in a variety of soils and climates. However, the
microorganism can be cultivated from soils where an epidemic of anthrax has occurred
(Todar, 2005). Domestic and feral animals commonly ingest B. anthracis when
consuming spore-containing soil. Animals develop anthrax either through the inhalation,
gastrointestinal, or cutaneous routes of infection, typically resulting in death.
Human anthrax infections may be transmitted via the cutaneous, inhalation, and
gastrointestinal routes of infection with an LD50 of approximately 8,000 to 40,000 spores
(“Bacillus anthracis”, 2005). Death is characteristically associated with a blood titer of
107 bacteria per milliliter of blood (Todar, 2005). The incubation period for B. anthracis
endospores is from 1 to 43 days in humans; however, endospores were recovered up to
100 days after exposure in a non-human primate study (“AHFS DI Bioterrorism Research
Manual”, 2002). The mortality rates of human anthrax infections differ due to mode of
infection and the administration of antibiotic treatment.
Cutaneous infections are the most common form of anthrax with an incidence rate
of ninety-five percent in the United States (“Anthrax”, 2005). A cutaneous infection is
caused when B. anthracis spores enter the body through a lesion or abrasion of the
epidermis often involving the head, the neck, and/or the upper extremities (“Cutaneous
anthrax management algorithm”, 2006). Once spores enter the break in the epidermal
layer, the infection continues as follows: papule formation in 1 to 17 days; vesicle forms
in 1 to 2 days post papule formation; and vesicle drying creates a black, necrotic escar
surrounded by edema and purple secondary vesicles (“AHFS DI Bioterrorism Research
Manual”, 2002). The mortality rate for cutaneous anthrax infection is 20% without
antibiotic treatment (“Anthrax”, 2005).
3Inhalation represents the second most common route by which anthrax infections
are transmitted. Anthrax acquired in this manner was originally known as “woolsorter’s
disease” and was uncommon in the United States prior to 2001. The onset of inhalation
anthrax varies, but incubation periods are approximately 10 days. B. anthracis spores are
inhaled into the lungs where the alveolar macrophages ingest the spores and transport
them to the mediastinal lymph nodes. (Murray et al, 2002) Germination of the vegetative
forms occurs in the alveolar macrophages. The vegetative cells are transported to the
mediastinal lymph nodes where they cause hemorrhagic mediasteinitis (“AHFS DI
Bioterrorism Research Manual”, 2002). Inhalation anthrax symptoms resemble
influenza, but may be differentiated from influenza by a widening of the mediasteinum
observed on chest x-ray. The inhalation infection is found to be more severe than anthrax
due to other routes of infection because edema and inflammation can lead to life-
threatening respiratory problems. Mortality rates in untreated inhalation anthrax human
patients can exceed 80% (“Anthrax”, 2005).
Gastrointestinal anthrax infection is the least common of all modes of infection
and has not been reported in the United States (“AHFS DI Bioterrorism Research
Manual”, 2002). Gastrointestinal infection is caused by the ingestion of infected food,
typically undercooked meat, from an infected animal. B. anthracis spores can cause
ulcers in the mouth or esophagus, the terminal ileum, and cecum (Murray et al, 2002).
Spores enter through a break in the mucosa thereby resulting in ulceration.
Gastrointestinal infections cause acute edema and ulceration that, when left untreated,
can quickly lead to sepsis. Mortality rates for untreated gastrointestinal anthrax infection
vary from 25%-75% (“Anthrax”, 2005).
4The infectious nature of anthrax is due to two separate virulence determinates: (1)
the capsule and (2) the three-part anthrax toxin. The capsule is composed of poly D-
glutamate; an isomer of the L-glutamate amino acid typically found in bacterial species
(Jones et al., 1985). The poly-D-glutamate capsule is non-toxic, but functions to elude
phagocytic cells of the immune system (Todar, 2005). Capsule genes are encoded on the
plasmid pX02 and can be transferred to non-capsulated bacteria via transduction (Todar,
2005). The second virulence determinate is the anthrax toxin that includes three factors.
These are designated as edema factor (EF), protective antigen (PA), and lethal factor (LF)
(Todar, 2005). The combination of EF and PA causes edema. The edema cripples the
immune system through exhaustion and dilution of antibodies and natural killer cells.
According to Todar (2005), the combination of LF and EF causes an increase in cAMP
that reduces the phagocyte’s ability to ingest. It also increases the amount of cytokine in
macrophages and lymphocytes, thereby causing the accumulation of immune response
cells in one area potentially blocking the circulatory system and airways. The LF factor
is not a well-understood molecule, but the crystalline structure is similar to the family of
enzymes known as mitogen-activated protein kinases. Mitogen-activated protein kinases
aid in disrupting cellular signaling and communication (Todar, 2005). The combination
of all three factors causes edema, necrosis, and finally death if not treated.
Due to the ability of B. anthracis to sporulate, spores can be carried through the
air and water and survive on inanimate objects. The organism has been designated a
Category A bioterrorism threat. According to the CDC (“ Bioterrorism Agents/
Diseases”, 2005) a threat must meet specific factors to be included as Category A
bioterrorism threat, and thesis include:
5 can be easily disseminated or transmitted from person to person
 result in high mortality rates, and have the potential for major public
health impact
 might cause public panic and social disruption
 require special action for public health preparedness.
Category A agents pose a possible threat to the health and security of the nation,
requiring the creation of a network of laboratories and regulations to perform research on
B. anthracis. Presently labs are classified using two systems. The two systems are
categorized based on the ability of the lab to safely work with hazardous biological and
chemical agents. One system is known as the Laboratory Response Network (LRN).
The LRN is a set of diagnostic laboratories used to identify biological and chemical
agents. LRN labs are labeled 1, 2, 3 for chemical agents, but for biological agents the
labs are labeled as sentential (identification), reference (investigation), and national
laboratories (bioforensics, research, select agent activity) (“The Laboratory Response
Network Partners in Preparedness”, 2005). The system was initiated by the CDC for
possible use in a bioterrorism situation for quick and effective identification. The second
system categorizes labs according to the National Institutes of Health (NIH) Guidelines
(“The need for biosafety laboratory facilities”, 2006). The NIH Guidelines assign
biosafety levels from one to four based on the threat of agents employed and the ability to
work with agents safely. These labs are generally research facilities and hospitals.
Biosaftey Level 4 would be utilized with extremely infectious biological agents.
B. anthracis can only be used in minimal quantities in laboratories lower than
Reference/ Biosafety Level 3. The use of B. anthracis at lower levels is discouraged due
to its infectious nature. Two avirulent strains are available: the Sterne strain lacks pX02
leaving the bacteria uncapsulated (Todar, 2005) and the Pasteur strain is void of pX01
6and therefore does not produce the toxin (Read et al., 2003). Avirulent strains of B.
anthracis are then available for laboratory use, but due to the missing genes are useless
for toxin studies.
Bacillus cereus can be used as a surrogate for B. anthracis. B. anthracis and B.
cereus are both part of the bacillus group named as the B. cereus group or B. cereus
sensu lato (Turnbull, 1999). The B. cereus group bacteria are all Gram-positive, spore-
forming, and rod-shaped bacteria. The differentiation between the “members” of the
group is difficult because of genotypic and phenotypic similarities. Some studies suggest
that B. anthracis and B. cereus should be considered one species because of the close
similarity in genomic sequence (Helgason et al., 2000). B. cereus is a similar bacterium
to B. anthracis in many aspects. Specifically, B. cereus and B. anthracis are exclusive
research targets because both are pathogenic to humans. Similar DNA, toxins, fatty
acids, and evolution enable the use of B. cereus as a surrogate for B. anthracis at a
Biosafety level 2-laboratory setting.
Genetic similarities have been revealed between B. cereus and B. anthracis. The
genome sequences of B. cereus and B. anthracis are completed or considered 12X
shotgun status (Tourasse et al., 2006). Ribosomal sequences in the 16S rRNA were
determined to be identical and only two differences were found in the 23S rRNA (Ash &
Collins, 1992). Tandem repeats of a specific B. cereus strain (KCTC 1661) were found
to be exact matches with B. anthracis strains when using variable number tandem repeat
analysis. (Kim et al., 2002) The genetic relationships between B. cereus and B. anthracis
are continually being researched due to newly found strains with more similarities.
7B. cereus and B. anthracis exhibit similar toxin and virulence profiles. B. cereus
is cited to cause an illness similar to inhalation anthrax (Hoffmaster et al., 2004). The B.
anthracis toxin plasmid pX01 has been discovered in strains of B. cereus. The pX01
plasmid’s backbone is similar to specific plasmid backgrounds found in isolated B.
cereus strain ATCC 10987 (Rasko et al., 2004). B. cereus G9241 carries an almost
complete pX01 plasmid known as pBCX01 (Hoffmaster et al., 2006). Also, the G9241
strain has the presence of a capsule. The capsule for B. cereus strain G9241 is not
composed of poly D-glutamate as in B. anthracis, but is a unique characteristic relating
virulence factors of the B. cereus and B. anthracis (Hoffmaster et al., 2006). Finally
emetic toxin (cereulide) of B. cereus synthetase genes are located on a plasmid with a
pX01 backbone (Ehling-Schulz et a.l, 2006).
PlcR transcriptional activator is an important component to the genetic
expression and regulation of B. cereus toxins. The PlcR has been found as a nonsense
mutation in B. anthracis (Gohar et al., 2002). Introduction of a functional PlcR activates
B. cereus virulence factors in B. anthracis (Mignot et al., 2001). The ability to activate
non-sense mutations in B. anthracis with a transcription factor from B. cereus further
correlates the toxin profiles. According to Mendelson et al. (2004), non-hemolytic
exotoxin genes have been found in B. anthracis with a 98% alignment. B. anthracis has
been found to secrete a component of the non-hemolytic toxin (Mendelson et al., 2004)
which may play a role in the diarrhea that can accompany gastrointestinal anthrax
(Friedlander, 2000).
While clearly distinguishable from other Bacillus species, the nature and relative
abundance of fatty acids produced by B. anthracis are found to be comparable to those of
8B. cereus (Kaneda, 1967). Kaneda (1977) states that B. cereus and B. anthracis both
produce anteiso/iso-C12 and anteiso/iso C13 fatty acids, which are not significantly
produced by the majority of bacilli. Also, fatty acid profiles 17:1 10c and a17:1 are
unique to B. cereus and B. anthracis (Whittaker, 2005). The similarities in fatty acid
composition of B. anthracis and B. cereus is indicative of the close similarity in the
biochemical activities involved in fatty acid metabolism (Kaneda, 1968).
Nonselective and selective media provide a method for discriminating B. cereus
and B. anthracis phenotypically. Useful phenotypic tests include motility, hemolysis on
sheep blood agar, gamma phage lysis, and D-glutamyl-polypeptide capsulation (Todar,
2005). B. cereus also produces -lactamases and is penicillin, ampicillin, and
cephalosporin resistant (Turnbull et al., 2004). Growth on differential media easily
distinguishes the two bacteria apart; however, recently discovered strains of both species
have given atypical results. Rare strains of B. cereus can be poorly hemolytic, minimally
motile, may be lysed by the gamma phage, and are susceptible to penicillin (Turnbull,
1999). The atypical phenotypic results make B. cereus and B. anthracis difficult to
distinguish with just the use of differential and biochemical tests.
The similarities between the two species make B. cereus an excellent surrogate
for B. anthracis. As a spore-forming, Gram-positive bacterim B. cereus is a member of
B. cereus sensu lato (Turnbull, 1999). B. cereus is 1µm to 3.0/5.0 µm in length, motile,
rod-shaped, and able to survive at a pH rage of 4.3 or 9.3 (Burgess & Horwood, 2006).
Most B. cereus strains are known to grow at moderate temperatures (mesophilic), yet
strains have been found to thrive at low temperatures (psychrophilic) with tolerant growth
temperature ranges from 8°C to 55°C (Burgess & Horwood, 2006). As a ubiquitous soil
9bacterium B. cereus can be transferred to animals and plants in contact with B. cereus
cultures in the soil (Helgason et al., 2000). B. cereus is a food borne human pathogen
which causes diarrheal and emetic forms of illness.
The CDC has a Foodborne Disease Outbreak Surveillance System that monitors
the occurrences and causes of foodborne-disease outbreaks (FBDOs) (Lynch et al, 2006).
Recent national known outbreaks include Escherichia coli tainted spinach, Salmonella
found in peanut butter, and Hepatitis A-contaminated green onions. Foodborne-disease
epidemics are easily spread through the food industry and can be illustrated by the
expansive infected area shown in Figure 1 from the Salmonella peanut butter outbreak
early in March of 2007 (“Salmonellosis”, 2007). It is possible for terrorists to use
foodborne diseases, such as the emetic and diarrheal diseases caused by B. cereus, to
cause extensive devastation. A pervasive food epidemic could have adverse effects on
medical services, food supply, and economics of a billion dollar food service industry.
Figure 1: A map of the reported cases of Salmonella poisoning from peanut butter in March of 2007
(“Salmonellosis”, 2007).
The disease caused by B. cereus is mainly associated with food poisoning. B.
cereus may be found in rice, spices, cereal, flour, vegetables, oils, meats, and milk
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(Burgess & Horwood, 2006). B. cereus food poisoning is related to rice 95% of the time
(Burgess & Horwood, 2006). The diarrheal disease is usually milder than the emetic
infection. Diarrheal B. cereus infection symptoms range from abdominal cramps, watery
stool, and rectal tenesmus (“Anthrax”, 2005 ; Burgess & Horwood, 2006). Symptoms
begin six to twelve hours after consumption of food and can last up to 24 hours
(“Anthrax”, 2005). The emetic infection is considered more acute due to the quick onset
of symptoms. An emetic infection causes symptoms of nausea and vomiting with an
onset 0.5 to 6 hours after the consumption of contaminated foods (“Anthrax”, 2005) and
symptoms can last up to 24 hours.
Different toxins produced by B. cereus cause the diarrheal and emetic infections.
Toxins are substances that are capable of causing disease when introduced to animal or
plant tissues (“Toxin”, 2004). Bacterial toxins are typically proteins, peptides, or
lipopolysaccharides that are divided into two groups, endotoxins and exotoxins.
Endotoxins are produced predominately by Gram-negative bacteria only and are outer
membrane structural components (lipopolysaccharides). Endotoxins are released through
lysis of the bacterial cell. Exotoxins are protein/peptide toxins and released by the
bacteria through cell membrane transport or cell lysis. Both Gram-negative and Gram-
positive bacteria produce exotoxins. The toxins of B. cereus are exotoxins.
The diarrheal toxins of B. cereus have been well documented. The five most
prominent toxins acknowledged to cause the diarrheal infection include hemolysin BL,
non-hemolytic enterotoxin, cytotoxin K, enterotoxin FM, and enterotoxin T. Hemolysin
BL and non-hemolytic enterotoxin are discussed in-depth below. Cytotoxin K was first
identified by Lund, De Buyser and Granum (2000) and is thought to cause necrotic
11
enteritis. Enterotoxin FM and entertotoxin T are both single polypeptide proteins
(Ghelardi, 2002). Little information is known about enterotoxin T and FM other than
their involvement in the diarrheal infection.
Hemolysin BL (HBL) is suspected to be the major diarrheal toxin of B. cereus
(Burgess & Horwood, 2006). HBL is a three-part enzymatic toxin that can only be
activated when all three components are present (Lund & Granum, 1997). The three
components consist of B, L1, and L2, which are not individually hemolytic. The
concentration of L1 and L2 determines the lytic capabilities and concentration of the B
component determines the diameter of the hemolysis ring (Burgess & Horwood, 2006).
Approximately half of B. cereus strains produce diarrheal enterotoxin (Schoeni & Wong,
1999). HBL is easily viewed on a Trypticase soy agar plate with 5% blood agar (Figure
2). The toxin causes incomplete hemolysis ring and is considered a -hemolysin.
Figure 2: Bacillus cereus Arnold strain demonstrating  and incomplete hemolysis.
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Another B. cereus diarrheal toxin is known as non-hemolytic enterotoxin (Nhe).
This toxin is also a three-component toxin and was first isolated from a B. cereus food
poisoning (Lund & Granum, 1999). The Nhe toxin is non-hemolytic but is shown to be
highly cytotoxic to Vero cells (Lund & Granum, 1997). The Nhe components are Nhe A,
Nhe B, and Nhe C (Lund & Granum, 1999) and not individually cytotoxic. The presence
of the Nhe A component can be determined by the TECRA VIA BDE biochemical test
(Beecher & Wong, 1994).
The B. cereus emetic toxin has been described as a single polypeptide known as
cereulide (Agata et al., 1995). Cereulide is a small, heat and acid stable cyclic
dodecadepsipeptide. Cereulide is closely chemically related to the potassium ionophore
valinomycin with a chemical structure of [cyclic D--Leu-D-Ala-L--Val-L-Val]3 and is
shown in Figure 3 (A) (B) (Agata et al., 1995). Cereulide size is relatively small at 1.2 kDA
(Carlin et al, 2006) and has been shown to be toxic to mitochondria (Mikkola et al, 1999)
Figure 3: (A) Cereulide Chemical Structure (Ehling-Shulz et al.,2006) (B) Valinomycin Chemical
Structure (Valinomycin, ND)
and human natural killer cells (Paananen et al., 2002),. Approximately 8µg of cereulide
kg-1 dry weight of food is toxic to humans and can cause serious acute illness
(Jääskeläinen et al., 2003). The presence of cereulide in cell cultures results in the
vacuolation of mitochondria (Kawamura-Sato et al., 2005) and is highly toxic to hepatic
A B
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cells and a major health concern (Andersson et al., 2004). Cereulide may be detected by
monkey emesis assay (Shinagawa et al., 1995), various cell culture toxicity assays (Agata
et al., 1995), boar sperm assay (Andersson et al., 2004), and damage to rat liver
mitochondria (Kawamura-Sato et al, 2005).
The manner in with B. cereus regulates cell membrane transport and regulation of
toxins production is important for a better understanding of the two types of infections.
The B. cereus toxins are exotoxins and therefore must be released through (1) cell lysis or
(2) transmembrane regulation. There is no evidence of cell lysis of B. cereus cells noted
in previous studies on the bacterium or toxins. Without literature regarding the use of
cell lysis of B. cereus to release toxins, it can be postulated that the toxins are released
through the cell membrane transport. Cell membrane fatty acids and emetic toxin
production could be correlated through the investigation of cell membrane composition.
The cytoplasmic membrane is a crucial part in the regulation of solute entrance
and exit of the cell. Cell membranes are made up of phospholipids and proteins
(Campbell & Reece, 2001). Phospholipids are the major component of all biological
membranes and fatty acids occur in nearly all-living organisms as the predominate
components of membrane phospholipids (Kaneda, 1977). Fatty acids are carboxylic
acids with long aphilic tails that can be saturated or unsaturated. Saturated fatty acids are
categorized into straight-chain, branched-chain, and cyclohexyl fatty acids. Only
monounsaturated fatty acids are found in bacteria. As a major part of the cytoplasmic
membrane, the fatty acid composition is crucial to understanding cell envelope transport.
Branched-chain fatty acids are common constituents of the lipids contained in
bacteria (Christie, 2006). B. cereus is made up of 80% branched-chain fatty acids
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(Kaneda, 1991). Branched–chain fatty acids are divided into iso, anteiso, and -alicyclic
methyl branched. The naming of iso or anteiso is dependent on the position of the methyl
group branching. If the methyl is on the penultimate carbon (one from the terminal
carbon) then the fatty acid is iso branched (Christie, 2006). However if the fatty acid is
on the ante-penultimate carbon (two from the terminal carbon) it is said to be anteiso
branched (Christie, 2006). -Alicyclic fatty acids are major contributors to membrane
composition in specific bacterial species and are present as minor contributors in most
other bacteria (Kaneda, 1991). These specific branched chain fatty acids are synthesized
in bacteria using specific primers and malonyl CoA (enzyme for fatty acid chain
elongation).
Branched-chain fatty acids are synthesized using specific primers that are unique
from the synthesis of other fatty acids. The synthesis of branched-chain acids is
important to help understand the mechanisms involved in regulating the cell membrane
composition of B. cereus. De novo synthesis of branched-chain fatty acids is done
through the use of two different primers (1) Short chain carboxylic acids (2) -keto acids
(Kaneda, 1991). Ruminal and mutant Bacillus subtilis bacteria typically use short chain
carboxylic acids as primers for branched-chain fatty acid synthesis (Kaneda, 1991).
Short chain carboxylic acid primers are not commonly used in branched-chain fatty acid
synthesis and must be supplemented by the addition of specific substrates into the media.
The second forms of primers used for branched-chain fatty acid synthesis are -keto
acids. The -keto acid primers derive from isoleucine, leucine, and valine (Kaneda,
1977). Branched-chain fatty acid synthesis with the use of -keto acids as primers is the
main synthesis pathway used by bacteria (Kaneda, 1991).
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The fatty acid composition of the bacterial cell envelope may be changed by
variable factors. Fatty acids ratios change when different stressors are introduced to the
environment. The stressors include desiccation, reduced temperature, and the presence of
soluble rice starch (Haque & Russell, 2004). The fluidity or rigidity of the cell membrane
is also changed with different proportion of fatty acids. It has been proposed that
branched-chain fatty acids function in the membrane may be used as an alternative to
double bonds to increase the fluidity because the oxidative nature of double bonds
(Christie, 2006). Guffanti et al. (1987) stated that changes in membrane fatty acids can
affect the overall change in the energy synthesis, specifically ATPase synthesis.
Branched-chain fatty acids must be present in minimal levels, stated to at 28%, for
growth for Bacillus species (Kaneda, 1991). Phospholipids have been found to play a
role in the transport of branched-chain amino acids in Pseudomonas aeruginosa and
Streptococcus cremoris (Kaneda, 1991).
Toxins and branched-chain fatty acids play an important role in the composition
and virulence of B. cereus. The relationship between the two has yet to be investigated
through scientific study. The purpose of this study is to determine whether the fatty acid
profiles and cytotoxicity assay results differ among B. cereus strains. It is hypothesized
that a relationship among cell membrane fatty acids, emetic toxin production, and
cytotoxicity does exist.
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CHAPTER II
MATERIAL AND METHODS
Selection and Maintenance of B. cereus strains
Four strains of B. cereus that differed phenotypically with regard to emetic toxin
production were selected for the present study (Table 1). B. cereus strains F4810/72 and
NC7401 are positive for emetic toxin production (Turnbull, 1999; Andersson et a.l,
1998). B. cereus Arnold strain was obtained from a soil sample found adjacent to
Oklahoma I-35 (Miller, 2005) and identified by Oklahoma State University-College of
Health Sciences Forensic Science Laboratory for Forensic Pathology and Infections
Disease. The B. cereus strain Arnold ability to produce emetic toxin is unknown, but
Table 1: Bacillus Cereus Strains.
.
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suspected to be non-emetic. The B. cereus strain ATCC 14579 (American Type Culture
Collection, Manassas, VA) is negative for the emetic toxin (Andersson et al, 1998).
The B. cereus strains were routinely maintained on Trypticase soy agar with 5%
sheep blood and kept at 0-8°C. Deep–stabs were made of each strain and kept on 2%
agar at room temperature
Analyses of B. cereus Growth
Trypticase soy agar plates with 5% sheep blood (TSA II) were streak inoculated
and incubated at 30±1˚C overnight. Confluent growth from each B. cereus strain TSA II
culture were used to inoculate to 10 ml of sterile brain heart infusion (BHI) and incubated
for 24 hours at 30±1˚C. 50ml of sterile BHI broth was added to a pre-warmed 250 ml
Nephelo culture flask (side arm). Overnight cultures were added drop wise to the BHI
broth until an optical density (OD) of 0.020 (OD620 nm) was obtained. 50 mililiters of the
inoculated media were used to perform analyses of growth. The samples aerated at 30
±1˚C with rapid shaking (180 rpm) (Lab-line table top Orbit Environ-Shaker). Optical
densities were recorded at 30-minute intervals until stationary phase was attained and
maintained for 24 hrs. Experiments were performed in triplicate from independent
cultures.
Culture Filtrate and Cell Sample Preparation
Early and late stationary phase optical densities were determined from analyses of
B. cereus growth and subsequent OD points were used for sample harvesting. The
cultures were removed from the incubator at OD 1.6-1.7 (early stationary phase) and 2.0
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(late stationary phase). Cultures were centrifuged at 10,000 x g for 10 minutes at 4°C.
10 ml of culture filtrate (CF) were enriched for cereulide through the partial purification
of cereulide. Partial purification of cereulide follows the method used by Finlay, Logan
and Sutherland (1999) modified by the use of BHI. Samples were heat-sterilized for 15
minutes at 121°C, sterile filtered using a 0.22 µm filter, frozen in liquid nitrogen, and
stored at -80°C.
The cell pellet, solid centrifuged material, from the centrifuged sample was used
to analyze fatty acids by gas chromatography/ mass spectral scans. The cell pellet was
washed with DiH20 three times and placed in sterile low temperature freezer vials. The
samples were frozen in liquid nitrogen and stored at -80°C.
HuH-7 Cell Line Maintenance
The cell line of choice was the human hepatoma cell line HuH-7 due to
availability and sensitivity of hepatic cells to cereulide. HuH-7 was obtained from Dr.
Rashmi Kaul at Oklahoma State University-CHS. The cell line was originally derived by
Nakabayashi et al. (1982) from a hepatocellular carcinoma that was found to replicate
continuously.
The HuH-7 cells were grown in 75-cm2 flasks (Falcon) at 37°C in 5% CO2 with a
humidified atmosphere. HuH-7 cells were cultivated in Dulbecco’s modified medium
(DMEM) containing high glucose, 2mM L-glutamine, 1mM sodium pyruvate
(Invitrogen, Carlsbad, CA), supplemented with 10% heat-inactivated fetal bovine serum
(30 minutes, 56° C, Atlanta Biologicals, Lawrenceville, GA), and 1% penicillin/
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streptomycin/glutamine. The cell line was grown to approximately 60% confluence and
harvested with Trypsin-EDTA (0.05% trypsin, 0.53 mM EDTA, GiBCO, Carlsbad, CA).
In Vitro MTT Cell Toxicity and Mitochondrial Permeability Assays
The in vitro 3-[4,5-dimethylithiazol-2-yl]-2,5-dipheyl tetrazolium bromide (MTT)
cell toxicity and mitochondrial permeability assays employed were both obtained from
Sigma-Aldrich in St. Louis, Missouri. Cells for both assays were trypsinized and
suspended in complete DMEM at 106/ml, and 125 µl were added to 88 of the wells of a
96-well microtiter plate. Black plates were used for the mitochondrial permeability
assay. The cultures were grown overnight for confluencey and adherence.
Toxicity analyses included valinomycin (positive control), BHI (negative
interference control), and CF samples. Valinomycin was originally solubilized in DMSO
and then diluted in complete DMEM. Valinomycin was serial diluted with a starting
concentration of 400ng/ml. Both BHI and CF samples were serial diluted in DMEM.
Over night cell culture media was removed by aspiration. 100 µl of toxicity samples
were added according to Figure 4. Once the toxicity samples were added to the wells, an
additional 100 µl of complete DMEM was added to the well and incubated for 48 hours.
At the end of the time period the in vitro MTT cell toxicity and the mitochondrial
permeability assays were performed according to the protocols stated by the
manufacturer.
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Figure 4: The contents of the 96-well microtiter plate in both the in vitro MTT cell toxicity and the
mitochondrial permeability assays.
Gas Chromatography/ Mass Spectral Fatty Acid Scans
The Gas Chromatography/ Mass Spectral experimental for fatty acids design was
performed according to Supelco, Inc Bulletin 767A (1977). Fatty acid methyl esters
(FAME) standard were obtained from Matrace Company (Pleasant Gap, PA). The
GCMS was an Aligent 6890 Series ALS GC coupled to a Aligent 5973 MSD with a
Restek RXI-5m3, 30m x 0.25mm x 0.25 film thickness, column. Cell pellets from
previous section were used.
All GCMS samples were analyzed using the following programmed method. The
initial ramp temperature was 150°C for 4 minutes. This was an increased to a final
temperature of 250°C at a rate of 6°C/min. Column head pressure of helium carrier gas
was set at 13.27 psi. Helium carrier was ultra high purity (99.99%). The split ratio was
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changed from 10:1 to 5:1 with a 1 µl sample size. The mass spectrum range was 35.0 to
550.0 amu for the entire scan due to 3-minute solvent delay.
Data Collection and Statistics
The optical densities recordings were plotted in a semi-logarithmic curve to
determine the stationary growth optical density points. The samples were graphed using
SigmaPlot Version 10 (2006) .
Mitochondrial permeability assay results did not warrant statistical analysis. The
in vitro MTT assay results were graphed using OD points at 570 nm and –log toxin
dilutions. The points were graphed using Graph Pad Prism 4. An ANOVA with
Tukey’s multiple comparison tests were used to determine significant differences among
B. cereus strains toxicity at early and late stationary growth phases. Student T-Tests were
performed for each individual strains OD points from early to late stationary growth
phases. Concentrations of the amount of heat stable toxin(s) of B. cereus strains were
determined by comparing them to the standard curve generated from valinomycin. The
concentrations were tested for statistical significance among and within individual
strains. Difference in toxicity from early and late stationary phases were determined
using Tukey’s multiple comparison test applied to an one-way ANOVA and Student T-
tests.
GCMS spectra results were analyzed for the presence of fatty acids in the
different strains. The area percent and most likely fatty acid from individual peaks
generated by ChemStation software (Allegen, 2003)  were normalized by the equation in
Figure 5. All graphs and analysis were performed using Graph Pad Prism 4 . All
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normalized fatty acid data were statistically analyzed using an ANOVA with Tukey’s
multiple comparison tests to determine the differences among the strains. Individual
strain differences were determined with a Student T-test. Analyses of fatty acid with
respect to branche were performed and statistically analyzed using Tukey’s multiple
comparison tests as applied to an ANOVA. All data were placed in tables and graphed.
Individual Area Percent for Identified Fatty Acid x 100 = Normalized Area Percent
Total Area Percent for All Identified Fatty Acids
Figure 5: Normalization of original area percent from GCMS library search report of fatty acid
extraction.
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CHAPTER III
RESULTS
Analyses of B. cereus Growth
The results for the analyses of B. cereus growth are demonstrated in Figure 6.
Under the experimental conditions early stationary phase began at 1.6-1.7 OD620nm,
approximately at 4-5 hours from the initial inoculation. Late stationary phase began at
OD620nm of 2.0; 9-10 hours from inoculation. The OD’s for early and late stationary
phases were used for all sampling for GCMS and cell toxicity assays
Figure 6: Growth Curves for Bacillus cereus Strains with Differing Virulence Factors.
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Table 2: B. cereus Regressions and Slopes from Exponential Growth Phase
Regression and slopes for all B. cereus strains were determined for the
exponential growth phase. The values were determined to not be significantly different.
In vitro MTT Assay
The in vitro MTT assay results for all strains at both early and late stationary
growth phases are shown in Figure 7 and Figure 8. Valinomycin was used as the positive
control standard for cytotoxicity with concentrations ranging from 400 ng/ml to 0.75
ng/ml. The LD50 for valinomycin in HuH-7 cell cultures was which is approximately 50
ng/ml at OD570nm at 0.4815.
Normal HuH-7 growth was at approximately OD 0.90 because this was the lower
limit to DMEM only controls. The mean OD for DMEM was 1.53 and the upper limit
being at OD 2.288. Any OD above 0.90 was determined to be normal HuH-7 growth and
below was determined to be due to cytotoxicity.
The relative toxicity of CF from the various B. cereus strains in early stationary
phase is shown in Figure 7. When these results were compared each strain to both
valinomycin and DMEM it is apparent that all B. cereus strains stayed above the OD 0.90
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point until the last dilution (CF dilution). Both NC7401 (OD 0.811) and F4810/72 (OD
0.269) were under the limits of normal HuH-7 growth in early stationary phase.
Figure 7: B. cereus Strains in vitro MTT Assay in Early Stationary Growth Phase.
The relative toxicity of CF from the various B. cereus strains in late stationary
phase are shown in Figure 8. B. cereus strains Arnold and ATCC 14579 optical density
points stay above the normal HuH-7 cell growth lower limits. F4810/72 last three optical
density points 0.2097, 0.713, and 0.76 are below the normal growth limitations and show
effects of cytotoxicity. NC7401 last two optical density points, OD 0.379 and OD 0.786,
are under normal HuH-7 cell growth and exhibit effects of cytotoxicity .
26
Figure 8: B. cereus Strains in vitro MTT Assay in Late Stationary Growth Phase.
Statistical analyses compared the relative toxicity of CF in early and late
stationary phases. Both early and late stationary phases produced the same statistical
results at a 95% confidence interval. In each comparison, F4810/72 differed from strains
Arnold and ATCC 14579. NC7401 also differed from ATCC 14579, but not from
Arnold. The results are summarized in Figure 9 and Figure 10.
Figure 9: A Comparison of B. cereus Strains Culture Filtrate in vitro MTT Assay in Early Stationary
Growth Phase.
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Figure 10: A Comparison of B. cereus Strains Culture Filtrate in vitro MTT Assay in Late Stationary
Growth Phase.
When the CF’s were examined individually, statistical analyses (Student T-test)
revealed that only ATCC 14579 differed from early to late stationary growth phase, when
comparing OD’s. The plots are shown in Figures 11-14.
Figure 11: In vitro MTT Assays of B. cereus Strain F4810/72 in Early and Late Stationary Growth
Phases.
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Figure 12: In vitro MTT Assays of B. cereus Strains NC7401 in Early and Late Stationary Growth
Phases
Figure 13: In vitro MTT Assays of B. cereus Strain Arnold in Early and Late Stationary Growth
Phases
Figure 14: In vitro MTT Assays of B. cereus Strain ATCC 14579 in Early and Late Stationary
Growth Phases
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CF optical densities from all B. cereus strains were compared to the standard
curve for valinomycin concentration (Table 3). The DMEM negative controls exhibited
background cytotoxicity concentrations (0.70425) and were subtracted from all B. cereus
values of heat stable toxin(s). Both non-emetic and emetic strains showed an increase in
cytotoxicity in early stationary growth phase. However, no significant differences were
found when using Tukey’s multiple comparison assays applied to an one-way ANOVA.
Differences were found in the late stationary phase growth with F4810/72 when
compared to the other stains (Table 4).
Table 3: B. cereus in vitro MTT Assay Heat-Stable Toxin(s) Concentration Results from in vitro
MTT Assay in Early and Late Stationary Growth Phases. Heat stable concentrations were derived
from heat-purified CF for cereulide, the first dilution point in the assays.
Table 4: Statistical Analyses of B. cereus Heat-Stable Toxin(s) Concentration Results using in vitro
MTT Assay in Early and Late Stationary Growth Phases.
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Significant changes in concentrations of heat stable toxin from early to late
stationary phase growth were analyzed by using Student T-tests and are shown in all
strains (Figure 15). The p-values, based on a 95% confidence interval, <0.001 for
F4810/72; 0.0485 for NC7401; 0.0395 for Arnold; and 0.0149 for ATCC 14579. The p-
values were based on a 95% confidence interval.
Figure 15: Comparison of B. cereus Heat-Stable Toxin(s) Concentrations using in vitro MTT Assay in
Early to Late Stationary Phase Growth
Mitochondrial Permeability Assay
The results from the mitochondrial permeability assay showed no differences
from the valinomycin control, CF dilutions, and DMEM dilutions (data not shown). The
samples fluoresced from 1.54 to 2.0 ratio of JC-1 aggregates to JC-1 monomers. JC-1
aggregates are healthy cells, while JC-1 monomers are apoptotic cells.
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Gas Chromatography/ Mass Spectra Fatty Acid Scans
Identified fatty acid names and abbreviations are shown in Table 5. An example of
electron ion mass spectra fatty acid extraction of F4810/72 late stationary phase sample is
shown in Figure 16. Area percentages from the library search report were normalized
using the equation in Figure 5. Normalized average area percentages are shown in Table 6
and Table 7.
Figure 16: Electron mass spectra of fatty acid extraction from B. cereus F4810/72 in late stationary
phase.
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Table 5: Identified Fatty Acids from four B. cereus strains.
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Table 6: Fatty Acid Composition for B. cereus strains in Early Stationary Growth Phase.
Table 7: Fatty Acid Composition of B. cereus strains in Late Stationary Growth Phase.
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The statistical analyses of early stationary growth phase are shown in Table 8.
F4810/72 has the most significant differences when compared to the other strains.
NC7401 is not notably different than ATCC 14579 (p-values > 0.05). F4810/72 and
Arnold have the greatest differences, with five fatty acids being significantly different.
At iC 13:0 all strains are differnt to Arnold. Throughout the strain comparisons between
iC13:0 and iC15:0 tended to differ more than between aC15:0 and aC17:0. When
compared to late stationary growth phases (Table 9), early stationary phase growth overall
has more deviation in fatty acid composition among the strains.
Table 8: Statistical Analyses of Fatty Acid Composition of B. cereus Strains in Early Stationary
Growth Phase.
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When late stationary phase fatty acid profiles were compared (Table 9) the strains
did not generally differ. At iC15:0, there was a significant difference between the fatty
acid content of the emetic strains and Arnold/ ATCC 14579 (Figure 17). At aC17:0,
NC7401 was significantly different from both Arnold and ATCC 14579.
Table 9: Statistical Analyses of Fatty Acid Composition of B. cereus Strains in Late Stationary
Growth Phase.
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Figure 17: A Comparison of B. cereus Strains Average Area Percent at iC15:0 in Late Stationary
Growth Phase.
Differences between fatty acid composition in early and late stationary phase fatty
acid profiles of individual B. cereus strains were statistically analyzed using a Student T-
test and shown in Table 10. In F4810/72 five long chain and one short chain fatty acid
changed from early to late stationary phase. With the exception of aC13:0, NC7401 short
chain fatty acids (iC13:0- iC15:0) show difference between early to late stationary
growth. At fatty acid aC17:0, both Arnold and ATCC 14579 showed changes between
early and late phase growths. Non-emetic strains showed changes at C15:0: iso for
Arnold and anteiso for ATCC 14579.
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Table 10: Statistical Comparison of Fatty Acid Composition from Early and Late Stationary Growth
Phases of Individual B. cereus Strains.
Other authors (Lawrence et al., 1991) have stated that a method of differentiating
between B. cereus and B. anthracis involves the ratio of iso to anteiso fatty acid
composition. Early stationary phase ratios of odd numbered iso and anteiso fatty acids
were compared. As noted in Table 11, F4810/72 is significantly different than Arnold at
each iso/anteiso ratio statistical comparison, while NC7401 and ATCC 14579 are
different in two comparisons.
Table 11: Statistical Analyses of Odd Numbered Iso and Anteiso Fatty Acid Ratios of B. cereus
Strains in Early Stationary Growth Phases
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Late stationary growth phase odd numbered iso and anteiso fatty acid composition
rations are shown in Table 12. Only F4801/72 differs from all other strains at
iC13:0/aC13:0 and iC15:0/aC15:0. All other strains show know difference from each
other at any iso/anteiso comparisons.
Table 12: Statistical Analyses of Odd Numbered Iso and Anteiso Fatty Acid Composition of B. cereus
Strains in Late Stationary Growth Phases
The average total area percentages for even iso, odd iso, and odd anteiso fatty
acids are shown in Table 13 and Table 14. The results showed differences in early
stationary growth phase between F4810/72 and the other strains for even iso and odd
anteiso fatty acids. Even iso fatty acids for F4810/72 and NC7401 are the only strains to
increase from early to late stationary growth phase. F4810/72 is the only strain to
increase in odd numbered anteiso fatty acids from early to late stationary phase.
Table 13: B. cereus Average Iso and Anteiso Branched-Chain Fatty Acid Area Percent in Early
Stationary Growth Phase.
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Table 14: B. cereus Average Iso and Anteiso Branched-Chain Fatty Acid Area Percent in Late
Stationary Growth Phase.
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CHAPTER IV
DISCUSSION
The purpose of the present study was to determine whether a correlation exists
among cell membrane fatty acid composition, emetic toxin production, and cytotoxicity
in B. cereus. Analyses of B. cereus growth, in vitro MTT assays, mitochondrial
permeability assays, and GCMS were employed.
Analyses of B. cereus Growth
The B. cereus strains exhibited similar patterns of growth with minimal
differences, regarding growth kinetics. Emetic strains remained in lag phase for a longer
period of time than did non-emetic strains. The reason for an extended lag phase and
subsequent separation in exponential growth phase could be due to undefined
physiological differences between the strains. Apetroaie et al. (2005) found that cereulide
producers, including F4810/72 and NC7401, present atypical physiological test results
when compared to the non-cereulide producers.
Growth rates are important to the present study, as they can also be indicative of
physiological differences between the strains. Growth rates for all B. cereus strains
employed exhibited no significant changes as assessed on the basis of exponential growth
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phase slopes. Also, the r-squared values of all strains were similar. R-squared values are
used to report “goodness of fit” or how well the points make a straight-line.
There is evidence to support harvesting the samples at later times, including 18
hours (Finland, Logan, & Sutherland, 2005), 30 hours (Kawamura-Sato, 2005), and 48
hours (Toh et al, 2004). The papers suggest longer incubation time ensure cereulide
production; however, longer incubation could induce sporulation. Sporulation was not an
objective for this study, so the time period and designation of OD points for early (1.6-
1.65 OD) and late (2.0) stationary phases were used to ensure that sporulation of the
cultures had not yet occurred.
In vitro MTT Assays
Valinomycin, the standard ionophore for assessing cereulide cytotoxicity and
concentration, was determined to have a LD50 of approximately 50 ng/ml for the HuH-7
cell line, a human hepatocellular carcinoma. This value is was high when compared to
that reported using a boar sperm assay by Haggblom et al. (2002), but this could be due
the ability of liver cells to filter toxins. The LD50 for the B. cereus strains examined here
could not be determined because the heat-stable toxin(s) from CF failed to reach lower
limits of the assay determined by valinomycin control (.047 OD). CF samples were
considered to contain heat stable toxin(s) rather than cereulide because no definitive
identification of cereulide was possible.
The final CF dilution point of the B. cereus strains from early stationary growth
phase produced cytotoxic effects on HuH-7 cells. F4810/72 exhibited a larger
concentration of heat-stable toxin(s) when compared to the other B. cereus strains. The
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increase in heat-stable toxin(s) concentration may be explained due to the fact F4810/72
has been reported by others to produce cereulide (Andersson et al., 1998). NC7401 and
Arnold exhibited comparable heat-stable toxin(s) concentrations in early stationary phase.
Strain NC7401 has been shown to produce less heat-stable toxin when compared to
F4810/72 (Andersson et al., 1998). The cytotoxicity results for ATCC 14579 show
minimal levels of heat stable toxin(s) at 1.31 ng/ml. ATCC is known to be negative for
cereulide production (Andersson et al, 1998).
Late stationary growth phase heat-stable toxin(s) production is significantly
different among the B. cereus strains. F4810/72, with a concentration of 20.56 ng/ml of
heat-stable toxin(s), was significantly different than NC7401, Arnold, and ATCC 14579
with p-values ranging from <0.01 to <0.001. F4810/72 and NC7401 are known cereulide
producers (Andersson et al., 1998) and would then be expected to produce greater
concentrations of heat stable toxin(s) than the non-emetic strains. Arnold and ATCC
14579 have produced 5.6 and 4.65 ng/ml of heat-stable toxin(s), respectfully. These
concentrations were not significantly different and may be typical of non-emetic B.
cereus stains. A clear distinction between emetic and non-emetic strains of B. cereus in
late stationary growth phase heat-stable toxin(s) concentrations was demonstrated to
exist.
The OD and heat-stable toxin(s) concentrations of B. cereus individual strains
were statistically compared in the transition of early to late stationary growth phases.
Only ATCC 14579 demonstrated significant OD decreases from early to late stationary
growth phase, however, decreases in all B. cereus strains were observed from early to late
stationary phase. The in vitro MTT assay revealed significant increase in heat-stable
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toxin(s) production for all strains. OD and heat-stable toxin(s) concentrations have an
inverse relationship. The decrease in OD exhibited by all strains correlates with an
increase in heat stable toxin(s) concentration from early to late stationary phase growth.
Heat-stable toxin(s) production in early stationary phase was less for all strains
than the concentrations produced in late stationary phase. The production of B. cereus
heat-stable toxin cereulide has been shown to begin in late exponential to early stationary
phases (Drobniewski, 1993). With the production of cereulide commencing before early
stationary phase detection of the toxin may not occur until late stationary phase due to an
insufficient amount of toxin to cause observable cytotoxic effects. The increase of heat-
stable toxin(s) concentration from early to late stationary phase in all strains correlates
with the previously shown production of heat-stable toxin cereulide. The elevation of
heat-stable toxin(s) concentrations for F4810/72 and NC7401 in late stationary phase
could have been due to the production of heat-stable toxin cereulide. However, the
importance of the non-emetic strains exhibiting cytotoxicity with known negative
cereulide production could be indicative of other heat-stable toxin(s) and cereulide could
not be distinguished from other toxins.
The in vitro MTT assay determined that the cytotoxicity and heat-stable toxin(s)
production of B. cereus emetic and non-emetic strains differ. In this study F4810/72 and
NC7401 were confirmed to produce increased heat-stable toxin(s) concentrations and
cytotoxicity; Arnold and ATCC 14579 were found to have decreased heat-stable toxin(s)
concentration and cytotoxicity. Arnold’s emetic toxin production was previously
undocumented, but determined to be non-emetic due to the heat-stable toxin(s)
concentration in late stationary growth phase being comparable to that of ATCC 14579.
44
Mitochondrial Permeability Assay
Triplicate results of the mitochondrial permeability assay were precise, yet proved
to be inconclusive. The ratio of JC-1 aggregates and monomers remained within the
range of 1.54 to 2.0 fluorescence. The lack of difference between the valinomycin
standard, DMEM, and CF dilutions from all B. cereus strains could be due to assay
insensitivity, use of fluorescent spectrometry rather than microscopy, or human error.
Gas Chromatography/ Mass Spectra Fatty Acid Scans
The fatty acid content of B. cereus has been previously been employed as a means
for differentiating species in the B. cereus group (Whittaker et al., 2005). The fatty acid
composition of different toxin-producing B. cereus strains has not yet been examined.
Gas chromatography/mass spectral scans were employed in the present study to
determine if differences in fatty acid composition exist among B. cereus emetic and non-
emetic strains.
The fatty acids identified from the four B. cereus strains in this study correlated
with those previously reported by Kaneda (1991), Whittaker et al (2005), and Lawrence
et al., (1991). The B. cereus strains in the present study displayed strain-specific
differences in fatty acid area content in each growth phase and individual strain fatty acid
differences occurred with regard to changes between the growth phases. Changes in fatty
acid composition can occur in response to temperature changes, pH, stress,
transportation, energy synthesis, and primer availability (Haque & Russell, 2004;
Kaneda, 1991; Guffanti et al., 1987; Beck et al., 2004). In order to eliminate
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physiological variables the B. cereus strains in this study were cultivated under standard
conditions.
Analyses of fatty acid composition of B. cereus strains in early stationary phase
growth revealed four general trends: (1) the majority of significant differences involved
B. cereus F4810/72 strain, especially as it differed from non-emetic strains; (2) a
preponderance of fatty acid differences were between iC13:0 and iC15:0 which
distinguished F4810/72 and NC7401 from non-emetic strains (3) NC7401 was not
significantly different than ATCC 14579, and (4) Arnold differs from F4810/72 and
NC7401 at iC15:0, which is a major contributor to B. cereus fatty acid composition
(Lawrence et al., 1991). Generally in early stationary phase growth, a separation of
emetic and non-emetic strains was exhibited, particularly involving strain F4810/72.
Late stationary growth phase fatty acid composition did not generally differ
among B. cereus strains as much as that seen in early stationary growth phase. There
were significant differences between the emetic and non-emetic strains in iC15:0, which
is known to be the largest branched-chain fatty acid produced by B. cereus (Lawrence et
al., 1991). F4810/72 and NC7401 exhibited greater amounts of iC15:0 than either Arnold
or ATCC 14579. Elevated iC15:0 could then be a distinguisher of emetic versus non-
emetic strains of B. cereus in late stationary phase growth. Also, fatty acid aC17:0
statistically differed from NC7401 than the non-emetic strains, which could help
discriminate this strain.
B. cereus strain-specific fatty acid content differed significantly in early and late
stationary growth phases. F4810/72 exhibited significant changes in longer chain fatty
acids, while NC7401 demonstrates the opposite; changes in shorter chain fatty acids.
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Overall, the fatty acid content of emetic strains was more likely to exhibit changes during
the transition from early to late stationary growth phase than in non-emetic strains. The
differences between early and late stationary growth phases exhibited by the emetic
strains could be representative of the differences in physiology or fatty acid synthases.
Odd numbered iso/anteiso branched chain fatty acids were used to distinguish B.
cereus from B. anthracis by Lawrence et al. (1991). In the present study, the ratios of
iso/anteiso branched-chain fatty acids were also shown to be distinguishing factors
among the four strains. For example, F4810/72 could be discriminated from all other
strains by virtue of iso/anteiso fatty acid content at iC13:0/aC13:0 and iC15:0/aC15:0 in
early and late stationary growth phases. F4810/72 was distinguished from NC7401,
Arnold, and ATCC 14579 with regard to iso/anteiso fatty acid content in both growth
phases. Lawrence et al. (1991) stated that the differences in iso/anteiso fatty acid content
ratios could be indicative of different fatty acid synthase activities.
Branched-chain fatty acids are generally synthesized from specific -keto acid
primers, specifically even numbered iso (valine primer), odd numbered iso (leucine
primer), and odd numbered anteiso (isoleucine primer) fatty acids (Beck et al., 2004).
Exogenous supplies of -keto acids have been shown to be assimilated into the
membrane in the form of branched-chain fatty, therefore increasing branched-chain fatty
acid composition (Beck et al., 2004; Zhu et al., 2005). Changes in area percent of -keto
acid primer branched-chain fatty acid derivatives provide evidence of the emetic strain
F4810/72 being different from non-emetic strains. F4810/72 and NC7401 exhibited
increases in even iso fatty acids as the early to late stationary growth phase transition
occurred, thereby indicating of increased valine specificity or availability. F4810/72 is
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the only strain when underwent an increase in odd numbered iso fatty acids when early
and late stationary phase were compared, thus an increase in leucine availability could be
suspected. All strains decrease in odd anteiso fatty acid composition potentially thereby
demonstrating a decrease in isoleucine abundance in the culture or the strains ability to
synthesize this -keto acid. The comparison of branched-chain fatty acid -keto acid
derivatives may further lead to a relationship between membrane composition and the
emetic toxin, cereulide, produced by B. cereus due to the -keto acid monomer
composition of cereulide.
The physiological ramifications of fatty acid content changes in bacteria have
been well cited throughout the literature. Generally, changes in fatty acid content occur
in response to temperature and pH changes causing physiological changes thereby
maintaining optimal membrane fluidity and enhance survival of the bacteria in the new
environment. A study on a protonophore-resistant mutant of Bacillus subtilis revealed
the change in fatty acid content to be associated with protonophore-resistance (Krulwich
et al., 1987). The B. subtilus fatty acid content has been noted to decrease
monounsaturated C16 (C16:1) by 50% and increase in the iso/anteiso C15:0 ratio
(Krulwich et al., 1987). The B. cereus cereulide-producing strains are known to exhibit
self-resistance towards cereulide (Ehling-Schulz et al., 2006). F4810/72 and NC7401
exhibit the same deduction in C16:1 and increase in iso/anteiso C15:0 ratio; where as, the
non-emetic show an increase in C16:1 fatty acid and iso/anteiso C15:0 ratio. This clear
difference between emetic and non-emetic strains may then confer self-resistance to
cereulide-producing strains of B. cereus.
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Distinguishing emetic and non-emetic strains through fatty acid composition was
possible, especially when discriminating the emetic strains and Arnold.
F4810/72 fatty acid content was distinguished from non-emetic strains. F4810/72 was
primarily different than non-emetic strains in early stationary phase growth and
iso/anteiso ratios. NC7401 has been shown to be similar both to emetic and non-emetic
strains, but could generally be differentiated from Arnold. Arnold and ATCC 14579
possess minimal significant differences in all fatty acid content comparisons were
considered alike. The most distinguishing factor was that F4810/72 and NC7401 were
distinguished from non-emetic strains at iC15:0 in early and late stationary phases of
growth.
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CHAPTER V
CONCLUSION
The results of this study led to several conclusions. First, analyses of B. cereus
growth results revealed similar growth patterns among the B. cereus strains. The ability
to study different strains in the same growth phase was a crucial step in the comparison of
the B. cereus strains. Subtle differences of the four B. cereus strains at lag and
exponential phases of growth were detectable, but the slopes revealed no statistical
differences between the strains, therefore growth rates are generally similar among the
strains under study.
Second, the results from the in vitro MTT assay provides a clear distinction
between emetic and non-emetic strains heat-stable toxin(s) production and cytotoxic
affects on HuH-7 cells line (hepatocellular carcinoma). The production of heat stable
toxin was elevated in known emetic strains F4810/72 and NC7401. The non-emetic
strains (Arnold and ATCC 14579) were found to cause decreased amounts of cytotoxicity
when compared to known emetic strains. The amplified heat-stable toxin(s) production
exhibited by emetic stains was determined to be due to the emetic toxin, cereulide.
Third, variations exist among the B. cereus strains when fatty acid composition
was compared. It was determined that in early stationary growth phase, the emetic strains
are different than the non-emetic strains in the analyses performed. While late
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stationary growth phases provided minimal discrepancies in all fatty acid analyses, clear
differences of emetic and non-emetic strains at iC15:0 could be differentiated. Another
distinguishing factor was the iso/anteiso fatty acid ratios of B. cereus strain F4810/72
when compared to B. cereus strains NC4701, Arnold, and ATCC 14579. Individual
strain analyses from early to late stationary growth phases produced noteworthy changes
in fatty acid content. Overall F4810/72 can be distinguished from the other strains
utilized in this study through cell membrane fatty acid content.
The potential for correlation among fatty acid composition, emetic toxin
production, and cytotoxicity of B. cereus does exist, but cannot be completely defined in
this study. However the present study demonstrates reproducible results that encourage
further study on this topic. Investigations that involve changing the fatty acid content of
the B. cereus strains and performing the same experimental design will provide greater
insight into the possible correlations.
Microbial forensic research will prove to be crucial to the better understanding of
bioterrorism agents. The information presented in this study could be used as a basis for
future research on the biochemical physiology of B. cereus and the pathology of the
diseases. The use of B. cereus as a bioterrorism agent is possible; however, more life
threatening agents, such as B. anthracis, would be more likely employed in a terrorism
event. Ultimately, future research in the possible relationship between the fatty acids and
toxin production of B. anthracis would be the main target of the knowledge gained from
this study.
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